ConductScience.org, home

Gene · 708

NIH grants1,264

NIH grants whose papers are about the gene, through NIH's grant-paper links.

321 to 340 of 1,264

Download this page as JSON
GrantTitleC1QBP papersNewest fiscal year
U24HD093483Primary Mitochondrial Disease Expert Curation Panel12023
P30ES006096Center for Environmental Genetics22022
R33AI140439Identification and characterization of chromatin regulators of HIV-1 latency22022
T32GM007388Predoctoral Training in Genetics and Molecular Biology22022
F30CA250249Mechanosensation in tumorigenesis and metastasis12022
F31EY031558Investigating Mitochodrial Homeostasis as a Pathological Mechanism of Age Related Macular Degeneration12022
F31LM013583Rule-based machine learning to address heterogeneity in high-dimensional survival data12022
F32GM137463Molecular mechanisms of the ACF chromatin remodeling complex12022
I01CX001211Role of Gut Microbial Translocation in Initiating Autoimmunity12022
K08CA230220Targeting casein kinase 1-alpha for cancer therapy12022
K08HL140178Mechanistic evaluation of a novel Wnt-responsive adult alveolar epithelial progenitor population during regeneration after diffuse alveolar damage12022
K99CA255936Mechanisms of translational output control in pancreatic cancer12022
P01CA217798Pancreatic Cancer Metastasis12022
P01HL040962Biobehavioral Studies of Cardiovascular Disease12022
P01HL108793Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)12022
P41GM103493A Research Resource for Ultra-sensitive High Throughput Proteomics12022
R01AA026086Alcohol-Induced Mitochondrial Derangements Cause Alveolar Macrophage Dysfunction12022
R01AI017828Murine Typhus12022
R01AI033144The Immunogenetics of Measles Immunity12022
R01AI097012Mode of action of a new Tat HIV-1 inhibitor12022

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/708/grants?page=17